• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA expands J&J's psoriasis drug for inflammatory bowel disease

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 11, 2024 at 11:12: PM
via The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's (JNJ.N) drug, Tremfya, to treat adults with a type of chronic inflammatory bowel disease, the company said on Wednesday.

article source
 




Top Bottom
Back
Quote